About Us
Hangzhou Qianxun Biotechnology Co., Ltd. is a technology-driven enterprise based on a platform for regenerative medicine materials, dedicated to providing innovative solutions for the global medical aesthetics field.
We firmly believe that future beauty and health stem from the deep mysteries of life science. Therefore, the company has established a dual-wheel business model driven by the "Medical Sector" and the "Consumer Sector," with "Material Innovation" as its foundation. In the Medical Sector, we specialize in ultra-high viscosity regenerative fillers and are building an international, first-class smart production line. In the Consumer Sector, we are launching high-end functional personal care brands based on our core bioactive ingredients.
By integrating the R&D capabilities of top scientific institutions, including the Ocean University of China and Zhejiang University, Qianxun Biotechnology is steadily advancing a Full Industry Chain Layout spanning specialty raw materials, medical devices, and end-user brands. Our aim is to become the bridge connecting cutting-edge biotechnologies with market demands.
Hangzhou Qianxun Biotechnology Co., Ltd. is a technology-driven enterprise based on a platform for regenerative medicine materials, dedicated to providing innovative solutions for the global medical aesthetics field.
We firmly believe that future beauty and health stem from the deep mysteries of life science. Therefore, the company has established a dual-wheel business model driven by the "Medical Sector" and the "Consumer Sector," with "Material Innovation" as its foundation. In the Medical Sector, we specialize in ultra-high viscosity regenerative fillers and are building an international, first-class smart production line. In the Consumer Sector, we are launching high-end functional personal care brands based on our core bioactive ingredients.
By integrating the R&D capabilities of top scientific institutions, including the Ocean University of China and Zhejiang University, Qianxun Biotechnology is steadily advancing a Full Industry Chain Layout spanning specialty raw materials, medical devices, and end-user brands. Our aim is to become the bridge connecting cutting-edge biotechnologies with market demands.
R&D and Production
We are establishing a dedicated laboratory for regenerative medicine materials, which will possess end-to-end R&D capabilities—from molecular structure design and raw material purification to innovative dosage form development. This lab serves not only as a source of innovation but also as a reflection of our "pharmaceutical-grade" R&D standards, ensuring the safety and efficacy of our products from the very origin.
We are currently constructing a smart production line compliant with GMP standards. The core focus of this line is the stable manufacturing of implantable medical devices characterized by ultra-high viscosity and high active ingredient content. Through full-process closed-loop management and online quality monitoring, we ensure the uniform quality, production efficiency, and rapid delivery of every product. This marks our critical leap from 'technical realization' to 'commercial delivery'.
Certificate & Intellectual Property
We have filed patent applications for core achievements such as cutting-edge medical aesthetic regenerative materials, establishing the company’s first technological moat. In the future, we will focus on three major technology platforms and gradually expand the scope of applications to include PLLA microsphere preparation processes, high-purity PDRN purification technology, decellularized matrix preparation technology, and more, systematically deploying global PCT patents.
Our quality management system strictly follows GMP standards and NMPA regulatory requirements. The registration and inspection of Class II medical devices is currently progressing in an orderly manner, and comprehensive preparations have been made for the clinical trials and registration applications of subsequent Class III medical devices.
